Measurement of tumor necrosis factor-α, leukotriene B4, and interleukin 8 in the exhaled breath condensate in patients with acute exacerbations of chronic obstructive pulmonary disease
Fanny WS Ko1, Ting-Fan Leung2, Gary WK Wong2, Jenny Ngai1, Kin W To1, Susanna Ng1, David SC Hui1
1Department of Medicine and Therapeutics; 2Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong
Background: Assessment of airway inflammation in the clinical course of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) may advance our understanding of the pathogenesis and treatment.
Objectives: To assess airway inflammation in patients during the course of AECOPD by serial analyses of their exhaled breath condensates (EBC).
Methods: Twenty-six patients with AECOPD (22 males, mean[SD] percentage predicted forced expiratory volume in one second (FEV1) 44.8 [14.3]), 11 with stable COPD, and 14 age and sex-matched healthy controls were studied. Patients with AECOPD were treated with systemic steroid and antibiotic for 7 days. EBC was collected from each patient with AECOPD on Day 5, 14, 30, and 60 post-hospitalization using EcoScreen (VIASYS Healthcare, USA) during tidal breathing over 10 minutes. Concentrations of tumor necrosis factor-α (TNF-α), leukotriene B4 (LTB4), and interleukin-8 (IL-8) were measured by enzyme-linked immunosorbent assay.
Results: The median (IQR) of TNF-α level on Day 5 was 5.08 (3.80–6 .32) pg/ml, which was lower than on Day 14 (5.84 [4.91–9.14] pg/ml, p = 0.017), Day 30 (6.14 [3.82–7.67] pg/ml, p = 0.045), and Day 60 (5.60 [4.53–8.80] pg/ml, p = 0.009). On Day 60, subjects receiving inhaled corticosteroid (ICS) had a lower level of TNF-α than those who were not (4.82 [4.06–5.65] vs 7.66 [5.48–10.9] pg/ml, p = 0.02). EBC LTB4 level did not change significantly during recovery from AECOPD whereas IL-8 was mostly undetectable.
Conclusions: EBC TNF-α level was low in patients receiving systemic steroid and antibiotic therapy for AECOPD. These findings suggest a potential role for serial EBC TNF-α for noninvasive monitoring of disease activity.
Keywords: COPD, exacerbation, exhaled breath condensate, TNF-α, LTB4
Readers of this article also read:
Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD
Khorasani N, Baker J, Johnson M, Chung KF, Bhavsar PK
Published Date: 4 February 2015
Schmid ST, Koepke J, Dresel M, Hattesohl A, Frenzel E, Perez J, Lomas DA, Miranda E, Greulich T, Noeske S, Wencker M, Teschler H, Vogelmeier C, Janciauskiene S, Koczulla AR
Published Date: 28 September 2012
Published Date: 2 November 2010
Joseph Finkelstein, Eunme Cha, Steven M Scharf
Published Date: 4 September 2009
Erik Bathoorn, Jeroen JW Liesker, Dirkje S Postma, Gerard H Koëter, Marco van der Toorn, et al
Published Date: 2 February 2009
L M G Steuten, K M M Lemmens, A P Nieboer, H JM Vrijhoef
Published Date: 22 December 2008
Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: Current and future perspectives
Noora Louhelainen, Marjukka Myllärniemi, Irfan Rahman, Vuokko L Kinnula
Published Date: 5 December 2008
Alveolar epithelial and endothelial cell apoptosis in emphysema: What we know and what we need to know
Mathieu C Morissette, Julie Parent, Julie Milot
Published Date: 2 December 2008
Zoë L Borrill, Kay Roy, Rupert S Vessey, Ashley A Woodcock, Dave Singh
Published Date: 7 March 2008
Maria Luisa Onor, Marianna Trevisiol, Eugenio Aguglia
Published Date: 15 April 2007